Trials Sponsors Conditions Drugs Pricing

Conditions

Diabetes Mellitus Obesity

Outcome Measures

Primary Outcomes (1)

Number of point-of-care glucose values
Mean number of point-of-care glucose measurements during hospitalization
3 days

Secondary Outcomes (1)

Severe hypoglycaemia
From day of admission to the day of data collection, i.e., November 14, 2024

Other Outcomes (2)

Diabetes treatment during hospitalization
From day of admission to the day of data collection, i.e., November 14, 2024
Insulin regimen during hospitalization
From day of admission to the day of data collection, i.e., November 14, 2024

Interventions

Routine care for people with diabetes, with or without obesity, in the hospital settingOther

Routine care for people with diabetes, with or without obesity, in the hospital setting, including routine pharmacological treatment for diabetes and obesity.

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Adults (age ≥ 18 years) with diabetes who are admitted to an internal medicine ward of a participating medical centre at the time of the study

You may qualify if:

Hospitalized at the time of the survey for any cause

Sponsors & Collaborators

Centre Hospitalier Universitaire Sétif, Service Médecine Interne (Algeria)
Type not reportedcollaborator
Rostov State Medical University
Type not reportedcollaborator

Study Sites (8)

Medical University of Vienna

Vienna, State of Vienna, 1090, Austria

General University Hospital in Prague

Prague, Czechia

University Hospital RWTH Aachen

Aachen, Germany

Hippokration General Hospital, Aristotle University of Thessaloniki

Thessaloniki, Greece

Rabin Medical Center, Hasharon Hospital

Petah Tikva, Israel

Riga East Clinical University Hospital

Riga, Latvia

Rostov State Medical University

Rostov-on-Don, Russia

MeSH Terms

Conditions

Diabetes MellitusObesity

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

Alexandra Kautzky-Willer, Prof
Medical University of Vienna
STUDY DIRECTOR

Enrollment

207 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: CROSS SECTIONAL
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Research Assistant (PhD)

Study Record Dates

First Submitted

November 6, 2024

First Posted

November 8, 2024

Study Start

November 13, 2024

Actual (reported)

Multinational Point Prevalence Study on the Management of Diabesity in Hospitals

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Other Outcomes (2)

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (8)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Other Outcomes (2)

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (8)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations